Found 37 results
Author [ Keyword(Desc)] Title Type Year
Filters: Author is van Breemen, Richard  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
4-Hydroxycoumarins
Feinstein DL, Gierzal K, Iqbal A, Kalinin S, Ripper R, Lindeblad M, Zahkarov A, Lyubimov A, van Breemen R, Weinberg G et al..  2019.  The relative toxicity of brodifacoum enantiomers.. Toxicol Lett. 306:61-65.
Rubinstein I, van Breemen R, Nosal DG, Weinberg G, Hershow RC, Feinstein DL.  2019.  Should Cytochrome P450 Inducers be Used to Accelerate Clearance of Brodifacoum from Poisoned Patients? Drugs R D. 19(1):67-71.
Animals
Feinstein DL, Gierzal K, Iqbal A, Kalinin S, Ripper R, Lindeblad M, Zahkarov A, Lyubimov A, van Breemen R, Weinberg G et al..  2019.  The relative toxicity of brodifacoum enantiomers.. Toxicol Lett. 306:61-65.
Saldivia N, Heller G, Zelada D, Whitehair J, Venkat N, Konjeti A, Savitzky R, Samano S, Simchuk D, van Breemen R et al..  2024.  Deficiency of galactosyl-ceramidase in adult oligodendrocytes worsens disease severity during chronic experimental allergic encephalomyelitis.. Mol Ther. 32(9):3163-3176.
Anticoagulants
Feinstein DL, Gierzal K, Iqbal A, Kalinin S, Ripper R, Lindeblad M, Zahkarov A, Lyubimov A, van Breemen R, Weinberg G et al..  2019.  The relative toxicity of brodifacoum enantiomers.. Toxicol Lett. 306:61-65.
Rubinstein I, van Breemen R, Nosal DG, Weinberg G, Hershow RC, Feinstein DL.  2019.  Should Cytochrome P450 Inducers be Used to Accelerate Clearance of Brodifacoum from Poisoned Patients? Drugs R D. 19(1):67-71.
Blood Coagulation
Rubinstein I, van Breemen R, Nosal DG, Weinberg G, Hershow RC, Feinstein DL.  2019.  Should Cytochrome P450 Inducers be Used to Accelerate Clearance of Brodifacoum from Poisoned Patients? Drugs R D. 19(1):67-71.
Cell Line, Tumor
Feinstein DL, Gierzal K, Iqbal A, Kalinin S, Ripper R, Lindeblad M, Zahkarov A, Lyubimov A, van Breemen R, Weinberg G et al..  2019.  The relative toxicity of brodifacoum enantiomers.. Toxicol Lett. 306:61-65.
Chronic Disease
Saldivia N, Heller G, Zelada D, Whitehair J, Venkat N, Konjeti A, Savitzky R, Samano S, Simchuk D, van Breemen R et al..  2024.  Deficiency of galactosyl-ceramidase in adult oligodendrocytes worsens disease severity during chronic experimental allergic encephalomyelitis.. Mol Ther. 32(9):3163-3176.
Cytochrome P-450 Enzyme Inducers
Rubinstein I, van Breemen R, Nosal DG, Weinberg G, Hershow RC, Feinstein DL.  2019.  Should Cytochrome P450 Inducers be Used to Accelerate Clearance of Brodifacoum from Poisoned Patients? Drugs R D. 19(1):67-71.
Disease Models, Animal
Saldivia N, Heller G, Zelada D, Whitehair J, Venkat N, Konjeti A, Savitzky R, Samano S, Simchuk D, van Breemen R et al..  2024.  Deficiency of galactosyl-ceramidase in adult oligodendrocytes worsens disease severity during chronic experimental allergic encephalomyelitis.. Mol Ther. 32(9):3163-3176.
Encephalomyelitis, Autoimmune, Experimental
Saldivia N, Heller G, Zelada D, Whitehair J, Venkat N, Konjeti A, Savitzky R, Samano S, Simchuk D, van Breemen R et al..  2024.  Deficiency of galactosyl-ceramidase in adult oligodendrocytes worsens disease severity during chronic experimental allergic encephalomyelitis.. Mol Ther. 32(9):3163-3176.
Enterohepatic Circulation
Rubinstein I, van Breemen R, Nosal DG, Weinberg G, Hershow RC, Feinstein DL.  2019.  Should Cytochrome P450 Inducers be Used to Accelerate Clearance of Brodifacoum from Poisoned Patients? Drugs R D. 19(1):67-71.
Fat Emulsions, Intravenous
Rubinstein I, van Breemen R, Nosal DG, Weinberg G, Hershow RC, Feinstein DL.  2019.  Should Cytochrome P450 Inducers be Used to Accelerate Clearance of Brodifacoum from Poisoned Patients? Drugs R D. 19(1):67-71.
Galactosylceramidase
Saldivia N, Heller G, Zelada D, Whitehair J, Venkat N, Konjeti A, Savitzky R, Samano S, Simchuk D, van Breemen R et al..  2024.  Deficiency of galactosyl-ceramidase in adult oligodendrocytes worsens disease severity during chronic experimental allergic encephalomyelitis.. Mol Ther. 32(9):3163-3176.
Half-Life
Rubinstein I, van Breemen R, Nosal DG, Weinberg G, Hershow RC, Feinstein DL.  2019.  Should Cytochrome P450 Inducers be Used to Accelerate Clearance of Brodifacoum from Poisoned Patients? Drugs R D. 19(1):67-71.
Feinstein DL, Gierzal K, Iqbal A, Kalinin S, Ripper R, Lindeblad M, Zahkarov A, Lyubimov A, van Breemen R, Weinberg G et al..  2019.  The relative toxicity of brodifacoum enantiomers.. Toxicol Lett. 306:61-65.
Hemorrhage
Rubinstein I, van Breemen R, Nosal DG, Weinberg G, Hershow RC, Feinstein DL.  2019.  Should Cytochrome P450 Inducers be Used to Accelerate Clearance of Brodifacoum from Poisoned Patients? Drugs R D. 19(1):67-71.
Humans
Rubinstein I, van Breemen R, Nosal DG, Weinberg G, Hershow RC, Feinstein DL.  2019.  Should Cytochrome P450 Inducers be Used to Accelerate Clearance of Brodifacoum from Poisoned Patients? Drugs R D. 19(1):67-71.
Feinstein DL, Gierzal K, Iqbal A, Kalinin S, Ripper R, Lindeblad M, Zahkarov A, Lyubimov A, van Breemen R, Weinberg G et al..  2019.  The relative toxicity of brodifacoum enantiomers.. Toxicol Lett. 306:61-65.
Inactivation, Metabolic
Rubinstein I, van Breemen R, Nosal DG, Weinberg G, Hershow RC, Feinstein DL.  2019.  Should Cytochrome P450 Inducers be Used to Accelerate Clearance of Brodifacoum from Poisoned Patients? Drugs R D. 19(1):67-71.
Lethal Dose 50
Feinstein DL, Gierzal K, Iqbal A, Kalinin S, Ripper R, Lindeblad M, Zahkarov A, Lyubimov A, van Breemen R, Weinberg G et al..  2019.  The relative toxicity of brodifacoum enantiomers.. Toxicol Lett. 306:61-65.
Lysosomes
Saldivia N, Heller G, Zelada D, Whitehair J, Venkat N, Konjeti A, Savitzky R, Samano S, Simchuk D, van Breemen R et al..  2024.  Deficiency of galactosyl-ceramidase in adult oligodendrocytes worsens disease severity during chronic experimental allergic encephalomyelitis.. Mol Ther. 32(9):3163-3176.
Male
Feinstein DL, Gierzal K, Iqbal A, Kalinin S, Ripper R, Lindeblad M, Zahkarov A, Lyubimov A, van Breemen R, Weinberg G et al..  2019.  The relative toxicity of brodifacoum enantiomers.. Toxicol Lett. 306:61-65.
Mice
Saldivia N, Heller G, Zelada D, Whitehair J, Venkat N, Konjeti A, Savitzky R, Samano S, Simchuk D, van Breemen R et al..  2024.  Deficiency of galactosyl-ceramidase in adult oligodendrocytes worsens disease severity during chronic experimental allergic encephalomyelitis.. Mol Ther. 32(9):3163-3176.

Pages